Skip to main content
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
editorial
. 2009 Mar;5(1):1–2. doi: 10.1007/BF03160972

The case report: A tool for the toxicologist

Anne-Michelle Ruha
PMCID: PMC3550335  PMID: 19343826

Full Text

The Full Text of this article is available as a PDF (86.0 KB).

Footnotes

Anne-Michelle Ruha, MD was named Case Report Editor forJMT, effective Volume 5.

References

  • 1.Albrecht J, Meves A, Bigby M. Case reports and case series fromLancet had significant impact on medical literature. J Clin Epidemiol. 2005;58(12):1227–1232. doi: 10.1016/j.jclinepi.2005.04.003. [DOI] [PubMed] [Google Scholar]
  • 2.Monahan BP, Ferguson CL, Killeavy ES, et al. Torsades de points occurring in association with terfenadine use. JAMA. 1990;264(21):2788–2790. [PubMed] [Google Scholar]
  • 3.Caravati EM, Erdman AR, Christianson G, et al. Ethylene glycol exposure: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2005;43(5):327–345. doi: 10.1080/07313820500184971. [DOI] [PubMed] [Google Scholar]
  • 4.Wax PM, Erdman AR, Chyka PA, et al. Beta-blocker ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2005;43(3):131–146. [PubMed] [Google Scholar]
  • 5.Oxford Centre for Evidence-based Medicine [webpage on the Internet]. Levels of Evidence [cited 27 Oct 2008]. Available from: http://www.cebm.net/index.aspx?o= 1025.
  • 6.Sorinola O, Olufowobi O, Coomarasamy A, et al. Instructions to authors for case reporting are limited: a review of a core journal list. BMC Med Educ. 2004;4:4–4. doi: 10.1186/1472-6920-4-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Tomaszewski C. The power of the case report. J Med Toxicol. 2006;2(4):139–140. doi: 10.1007/BF03161180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. doi: 10.1038/clpt.1981.154. [DOI] [PubMed] [Google Scholar]
  • 9.Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41(4):674–680. doi: 10.1345/aph.1H423. [DOI] [PubMed] [Google Scholar]
  • 10.Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300. [PMC free article] [PubMed] [Google Scholar]
  • 11.Kelly WN, Arellano FM, Barnes J. Guidelines for submitting adverse event reports for publication. Drug Safety. 2007;30(5):367–373. doi: 10.2165/00002018-200730050-00001. [DOI] [PubMed] [Google Scholar]
  • 12.Ansaloni L, Catena F, Moore EE. WJES and case reports/case series. World J Emerg Surg. 2007;2:11–11. doi: 10.1186/1749-7922-2-11. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES